Literature DB >> 15265700

Nuclear shuttling and TRAF2-mediated retention in the cytoplasm regulate the subcellular localization of cIAP1 and cIAP2.

Barbara Vischioni1, Giuseppe Giaccone, Simone W Span, Frank A E Kruyt, Jose A Rodriguez.   

Abstract

Dynamic subcellular localization is an important regulatory mechanism for many proteins. cIAP1 and cIAP2 are two closely related members of inhibitor of apoptosis (IAP) family that play a role both as caspase inhibitors and as mediators of tumor necrosis factor (TNF) receptor signaling. Here, we report that cIAP1 and cIAP2 are nuclear shuttling proteins, whose subcellular localization is mediated by the CRM1-dependent nuclear export pathway. Blocking export with leptomycin B induces accumulation of both endogenous cIAP1 and epitope-tagged cIAP1 and cIAP2 in the nucleus of human cancer cells. We have identified a new CRM1-dependent leucine-rich nuclear export signal (NES) in the linker region between cIAP1 BIR2 and BIR3 repeats. Mutational inactivation of the NES, which is not conserved in cIAP2, reduces cIAP1 nuclear export. Forced relocation of cIAP1 to the nucleus did not significantly alter its ability to prevent apoptosis. Interestingly, co-expression experiments showed that the cIAP1 and cIAP2-interacting protein TNF receptor-associated factor 2 (TRAF2) plays an important role as regulator of IAP nucleocytoplasmic localization, by preventing nuclear translocation of cIAP1 and cIAP2. TRAF2-mediated cytoplasmic retention of cIAP1 was reduced upon TNFalpha treatment. Our results identify molecular mechanisms that contribute to regulate the subcellular localization of cIAP1 and cIAP2. Translocation between different cell compartments may add a further level of control for cIAP1 and cIAP2 activity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265700     DOI: 10.1016/j.yexcr.2004.04.040

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  13 in total

1.  Overexpression of cellular inhibitor of apoptosis protein 2 is an early event in the progression of pancreatic cancer.

Authors:  Irene Esposito; Jörg Kleeff; Ivane Abiatari; Xined Shi; Nathalia Giese; Frank Bergmann; Wilfried Roth; Helmut Friess; Peter Schirmacher
Journal:  J Clin Pathol       Date:  2006-06-14       Impact factor: 3.411

2.  Cellular inhibitor of apoptosis 2 (cIAP2) restricts neuroinflammation during experimental autoimmune encephalomyelitis.

Authors:  Debolina D Biswas; Rebecca K Martin; LaShardai N Brown; Karli Mockenhaupt; Angela S Gupta; Michael J Surace; Anuj Tharakan; Jessie W Yester; Reetika Bhardwaj; Daniel H Conrad; Tomasz Kordula
Journal:  J Neuroinflammation       Date:  2022-06-19       Impact factor: 9.587

3.  Nuclear-to-cytoplasmic relocalization of the proliferating cell nuclear antigen (PCNA) during differentiation involves a chromosome region maintenance 1 (CRM1)-dependent export and is a prerequisite for PCNA antiapoptotic activity in mature neutrophils.

Authors:  Dikra Bouayad; Magali Pederzoli-Ribeil; Julie Mocek; Céline Candalh; Jean-Benoît Arlet; Olivier Hermine; Nathalie Reuter; Noélie Davezac; Véronique Witko-Sarsat
Journal:  J Biol Chem       Date:  2012-07-30       Impact factor: 5.157

4.  Classical and/or alternative NF-kappaB pathway activation in multiple myeloma.

Authors:  Yulia N Demchenko; Oleg K Glebov; Adriana Zingone; Jonathan J Keats; P Leif Bergsagel; W Michael Kuehl
Journal:  Blood       Date:  2010-01-06       Impact factor: 22.113

5.  cIAP1-dependent TRAF2 degradation regulates the differentiation of monocytes into macrophages and their response to CD40 ligand.

Authors:  Alban Dupoux; Jessy Cartier; Séverine Cathelin; Rodolphe Filomenko; Eric Solary; Laurence Dubrez-Daloz
Journal:  Blood       Date:  2008-09-30       Impact factor: 22.113

6.  Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma.

Authors:  Jonathan J Keats; Rafael Fonseca; Marta Chesi; Roelandt Schop; Angela Baker; Wee-Joo Chng; Scott Van Wier; Rodger Tiedemann; Chang-Xin Shi; Michael Sebag; Esteban Braggio; Travis Henry; Yuan-Xiao Zhu; Homer Fogle; Tammy Price-Troska; Gregory Ahmann; Catherine Mancini; Leslie A Brents; Shaji Kumar; Philip Greipp; Angela Dispenzieri; Barb Bryant; George Mulligan; Laurakay Bruhn; Michael Barrett; Riccardo Valdez; Jeff Trent; A Keith Stewart; John Carpten; P Leif Bergsagel
Journal:  Cancer Cell       Date:  2007-08       Impact factor: 31.743

7.  The E3 ubiquitin ligase cIAP1 binds and ubiquitinates caspase-3 and -7 via unique mechanisms at distinct steps in their processing.

Authors:  Young Eun Choi; Michael Butterworth; Srinivas Malladi; Colin S Duckett; Gerald M Cohen; Shawn B Bratton
Journal:  J Biol Chem       Date:  2009-03-03       Impact factor: 5.157

8.  cIAP1/2 are direct E3 ligases conjugating diverse types of ubiquitin chains to receptor interacting proteins kinases 1 to 4 (RIP1-4).

Authors:  Mathieu J M Bertrand; Saskia Lippens; An Staes; Barbara Gilbert; Ria Roelandt; Jelle De Medts; Kris Gevaert; Wim Declercq; Peter Vandenabeele
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

9.  TNF stimulates nuclear export and secretion of IL-15 by acting on CRM1 and ARF6.

Authors:  Suidong Ouyang; Hung Hsuchou; Abba J Kastin; Weihong Pan
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

10.  A functional map of NFkappaB signaling identifies novel modulators and multiple system controls.

Authors:  Thomas A Halsey; Longlong Yang; John R Walker; John B Hogenesch; Russell S Thomas
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.